Sequenom Gets Final Approval for Class Action Settlement

Sequenom agreed to pay shareholders $14 million to settle a class action suit filed months after the firm's stock plummeted in the wake of an announcement regarding the mishandling of data on the firm's SEQureDx test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories